Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Froniglutide in Patients With Idiopathic Inflammatory Myopathy (\"FROniGlutide Study\")
Epistemonikos ID: e358137ae112e73ac4eb1defe862b2a30af69835
First added on: Feb 19, 2024